Odin Vision receives NIHR funding to accelerate its AI technology for patient benefit

NIHR (National Institute for Health Research) has recognised Odin Vision as one of the companies to benefit from its new funding stream which accelerates...

UCLB spinout Freeline Closes $120 Million Series C Financing Round

Freeline, a biotechnology company focused on developing curative gene therapies for chronic systemic diseases, today announced the closing of a $120 million extended Series C financing. The financing augments Syncona’s...

New director takes the helm

Teesside University’s £22m National Horizons Centre opened last September with two objectives, to drive research into bioprocessing and to plug the yawning skills gap. Co-author...

Priority response plan (prp) for bio-decontamination of a biopharmaceutical production facility

Multinational Biopharmaceutical Company, Singapore - case study EXECUTIVE SUMMARY A multinational biopharmaceutical company in Asia, was looking to introduce a rigorous plan to ensure high-level bio-decontamination...